Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2005
11/17/2005CA2565215A1 Method and system to remove soluble tnfr1, tnfr2, and il2 in patients
11/17/2005CA2564796A1 Anti-aging effects of substance p
11/17/2005CA2564202A1 Ammonium/ammonia transporter
11/17/2005CA2563508A1 Myosin light chain kinase inhibitors and methods of use
11/17/2005CA2563505A1 Protease mixtures for degrading gluten in foodstuffs
11/17/2005CA2563400A1 Medicament for the treatment of fungal infections, particularly aspergillosis
11/17/2005CA2562552A1 Hybrid recombinases for genome manipulation
11/17/2005CA2560865A1 Cancer associated antigens
11/17/2005CA2560264A1 Gm1 promoter and use thereof
11/16/2005EP1595954A1 Human papilloma virus inhibition by antisense oligonucleotides
11/16/2005EP1595951A1 Diagnosis and treatment of diseases using peptides which are bound by specific anti-anti-t-cell receptor vbeta antibodies
11/16/2005EP1595890A2 Synthetic peptide inhibitors of HIV transmission
11/16/2005EP1595549A1 Dispersant for sustained release preparations
11/16/2005EP1595547A2 Use of the growth factor AMP for the treatment of gastrointestinal injuries and acute renal failure
11/16/2005EP1595544A1 Remedy for diabetes
11/16/2005EP1595543A2 Antineoplastic pharmaceutical compositions comprising taurolidine or taurultam and 5-fluorouracil
11/16/2005EP1595539A1 Drug for reducing side effects in ribavirin interferon combination therapy
11/16/2005EP1595532A2 Sustained release of peptides from pharmaceutical compositions
11/16/2005EP1594989A2 Methods for the early diagnosis of ovarian cancer
11/16/2005EP1594983A2 Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long qt syndrome
11/16/2005EP1594969A2 Active immunization to generate antibodies to soluble a-beta
11/16/2005EP1594965A2 Fusion proteins of interferon alpha muteins with improved properties
11/16/2005EP1594964A2 Oligonucleotides which inhibit the expression of the ob-rgrp protein and method for detection of compounds modifying the interaction between the proteins of the ob-rgrp family and the leptin receptor
11/16/2005EP1594960A2 Human cyclooxygenase-3 and uses thereof
11/16/2005EP1594896A1 Modified soluble t cell receptor
11/16/2005EP1594895A1 Growth factor complexes and modulation of cell migration and growth
11/16/2005EP1594894A2 Mtor kinase-associated proteins
11/16/2005EP1594892A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
11/16/2005EP1594891A1 Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof
11/16/2005EP1594889A2 Nell peptide expression systems and bone formation activity of nell peptide
11/16/2005EP1594541A2 Method and compositions for the treatment of meconium aspiration syndrome
11/16/2005EP1594539A2 Compositions for modulating immune cell activity and methods for detection thereof
11/16/2005EP1594532A2 Methods and compositions for the inhibition of cathepsins
11/16/2005EP1594531A1 Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof
11/16/2005EP1594530A2 Albumin fusion proteins
11/16/2005EP1594529A2 Analogues of glp-1
11/16/2005EP1594528A1 New pharmaceutical compositions based on anticholinergics and soluble tnf receptor fusion proteins
11/16/2005EP1594527A2 Vegf-b and pdgf modulation of stem cells
11/16/2005EP1594526A1 Methods for promoting wound healing and/or reducing scar formation
11/16/2005EP1594525A1 Regulation of allergen induced gene
11/16/2005EP1594524A2 Use of tryptanthrin compounds for immune potentiation
11/16/2005EP1594523A2 Pharmaceutical botulinum toxin compositions
11/16/2005EP1594522A1 Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases
11/16/2005EP1594521A2 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof
11/16/2005EP1594520A2 Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis
11/16/2005EP1594519A2 Cytomodulating peptides for treating interstitial cystitis
11/16/2005EP1594518A2 Novel peptide inhibitor of hiv fusion that disrupts the internal trimeric coiled-coil of gp41
11/16/2005EP1594517A2 Methods and compositions for the treatment of gastrointestinal disorders
11/16/2005EP1594516A1 Herbal compositions for prostate conditions
11/16/2005EP1594492A2 Novel inhibitors of formation of advanced glycation endproducts (ages)
11/16/2005EP1594447A2 Compositions and methods for the diagnosis and treatment of tumor
11/16/2005EP1594446A2 CALCIUM-SENSING RECEPTOR 2 (CaR2) AND METHODS FOR USING
11/16/2005EP1594444A2 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
11/16/2005EP1594439A2 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS
11/16/2005EP1594437A2 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins
11/16/2005EP1594436A2 Polymer conjugates of mutated neublastin
11/16/2005EP1594435A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
11/16/2005EP1594434A2 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus
11/16/2005EP1594433A2 Cancer therapy sensitizer
11/16/2005EP1487472A4 Stabilization of hypoxia inducible factor (hif) alpha
11/16/2005EP1463823A4 Methods of increasing endogenous erythropoietin (epo)
11/16/2005EP1368419B1 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1319082B1 Expression vectors containing hybrid ubiquitin promoters
11/16/2005EP1309338B1 Pharmaceutical composition comprising trkaig2 for use in the prevention and/or treatment of cancer
11/16/2005EP1274459B1 Sustained release formulations comprising growth hormone
11/16/2005EP1263458B1 Lowering serum cholesterol
11/16/2005EP1221966B1 Use of a parathyroid hormone for reducing the risk of cancer
11/16/2005EP1213353B1 Peptide leukotriene receptor
11/16/2005EP1196450B1 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis
11/16/2005EP1146857B1 Materials and methods for making improved micelle compositions
11/16/2005EP1131090B1 Use of paraoxanase-1 (pon-1) to decrease atheroma formation and hypercholesterolemia
11/16/2005EP1068328B1 Treatment and diagnosis of staphylococcal infections
11/16/2005EP1011635B1 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
11/16/2005EP0979089B1 Methods for using macrocyclic lactone compounds as multidrug resistance reversing agents in tumor and other cells
11/16/2005EP0970211B1 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection
11/16/2005EP0909322B1 Antiviral ricin-like proteins
11/16/2005EP0904099B1 Pharmaceutical formulation containing human growth hormone, histidine and a non-ionic detergent
11/16/2005EP0876395B1 Inhibitors of interleukin-1beta converting enzyme
11/16/2005EP0873406B1 Protein induced by deprenyl
11/16/2005EP0871703B1 Dna encoding glutamate gated chloride channels
11/16/2005EP0832232B1 Kunitz type plasma kallikrein inhibitors
11/16/2005EP0741793B1 Method for preparing recombinant adeno-associated viruses (aav), and uses thereof
11/16/2005EP0651811B1 K. lactis rp28 ribosomal protein gene promoter and use thereof
11/16/2005EP0556207B2 Modified human tnfalpha (tumor necrosis factor alpha) receptor
11/16/2005EP0477295B2 Platelet aggregation inhibitors
11/16/2005CN1697878A Novel peptides having cAMP producing activity
11/16/2005CN1697648A Azithromycin dosage forms with reduced side effects
11/16/2005CN1697647A Liquor and method for restraining ache, inflammation and cartilage degradation
11/16/2005CN1695735A Application of kininogenase of human urine in preparing medication for treating pyemia
11/16/2005CN1695734A Medication combination of kinase of fermented soybean in microcapsule, and preparation method
11/16/2005CN1695733A Wood louse analgesia peptide, preparation method and application
11/16/2005CN1227361C Method of expressing thymus peptide alpha by yeast and use thereof
11/16/2005CN1227360C Tumor-associated antigen derivatives from MAGE family, and nucleic acid sequence encoding them
11/16/2005CN1227359C Down-regualtion resistant C3 convertase
11/16/2005CN1227265C Antibodies to CCR5
11/16/2005CN1227264C Immunogenic peptides derived from MAGE and use thereof
11/16/2005CN1227263C Peptide diagnostic and therapeutic agent for autoimmune diseases
11/16/2005CN1227261C Monocyclic compounds with four bifunctional residues having NK-2 antagonist action, its preparation, medicine compositions and uses
11/16/2005CN1227035C Conjugates and method for production thereof, and their use for transporting molecules via biological membranes
1 ... 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 ... 3163